Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Neoplasms 23 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 14 Stomach Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 12 Pancreatic Neoplasms 10 Leukemia, Myeloid, Acute 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Hematologic Neoplasms 9 Head and Neck Neoplasms 9 Carcinoma, Hepatocellular 9 Squamous Cell Carcinoma of Head and Neck 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Endometrial Neoplasms 8 Myasthenia Gravis 7 Melanoma 7 Uterine Cervical Neoplasms 6 Recurrence 6 Rectal Neoplasms 6 Neoplasms by Site 6 Neoplasms by Histologic Type 6 Lymphoma 6 Leukemia 6 Urinary Bladder Neoplasms 5 Neoplasms, Plasma Cell 5 Infections 5 Colonic Neoplasms 5

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Ovarian Carcinosarcoma × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡